12�TCOG �� 2003.9

TCOG�� !"#

TCOG�� !!"#$%&TCOG�� !

�� !"#$%

�� !"�� �� !"#

�� !"26 ���� !"12 �

�� !" 2003 � 8 � 2�� !"#$%

�� !"#$%

1.�� !"#$%&'()*�A Phase II

Trial of Induction Chemotherapy and Con-

comitant Chemoradiotherapy in Locally Ad-

vanced Pancreatic Cancer Patients��

2.�� !"#$%&'()*+,-./01

��A Phase III Trial of Concomitant

Chemoradiotherapy in Locally Advanced

Pancreat ic Cancer Pat ients : Low-dose

Twice-weekly versus High-dose Weekly

Gemcitabine��

3.�� !"#$ %&'() %*+,-.

���Preliminary Study Protocol Concept

for Unresectable Locally Advanced Pan-

creatic Carcnoma��

4.�� !"#$ %&'() %*+,-

�� !"#$%�� !"#$%&'()

�� !"#$%�

�� !"#$%&

�� !"�� �� !"#

� � ���� �� !"#$

�� !" 41 ���� !"21 �

�� !" 2003 � 8 � 9�� !"#$%

�� !"

1.�� !"#$%&'()*

2.�� !"#$%&'()*+,-./�A

Phase II Study of Postoperative Local Irra-

diation plus Oral Thalidomide in Glioblas-

toma Multiforme��

�� !"#$

�� !"�� �� !"#

� � ���� �� !"#

�� !" 27 ���� !"18 �

�� !" 2003 � 8 � 9�� !"#!$

�� !"

1.�� T1899�� !�A Multi-Center Sur-

vey of HPV in Cervical Intraepithelial Neo-

plasia (CIN) with Longitudinal Follow-up

of LSIL Cases��� !"#$%&'()

LSIL�� !"#

2.�� T1E01�� !�Adjuvant Therapy

After Radical Hysterectomy for Patients

Who Have Stage Ib-IIa Cervical Carcinoma

With Pelvic Lymph Node Metastases���

�� !"#$%�&'()*+,-./%

�� !"#$�%&'

3.�� !"#$%&"'()*+,-./

�Thalidomide as Maintenance Therapy for

Advanced Epithelial Ovarian Carcinoma

Completely Responded to Surgery and Che-

motherapy�� PI�� !"#$%&'()

�� !"#NIRB��

4.�� !"#$%&'()*+,-./01

�� !"#$%&'()*+,-!"%.

�� !"#$%&'(

TCOG �� 2003.9�13

TCOG�� !"#

`çåÑÉêÉåÅÉ=çå=íÜÉ=aá~Öåçëáë=~åÇqêÉ~íãÉåí= çÑ= k~ë~ä= khLq= `ÉääióãéÜçã~

�� ! 2003 � 8 � 16�� !"#$%

� Nasal NK/T Cell Lymphoma�� !"�

�� !"#$%&'()*+,-�./01

�� !"#$%&'�()*"#+,-#%

�� !"#$%&'()*+,-."/01

�� !"#$%&'

� �� !"#$%&"'�Nasal NK/T Lym-

phoma in Taiwan�

� �� !"#$%&'�Clinical Features

and Management of Sinonasal NK/T Cell

Lymphoma�

� �� !"#$%&'�Radiologic Ex-

aminations, Staging, and Radiation Therapy

of Nasal NK/T Cell Lymphoma�

��� !"#$% &'() !"*+,

��Treatment Outcome and Patterns of

Failure in 77 Patients with Sinonasal NK/T

Cell Lymphoma in Taiwan�

��� !"#$%&'�Clinical Experience

of Nasal NK/T Cell Lymphoma in MKMH�

��� !"#$%&'�Treatment and Out-

come T/NK Cell Lymphoma: Experience of

VGH-Taipei General Hospital�

��� !"#$%&'�Clinical Experience

of Nasal NK/T Cell Lymphoma in CCH�

��� !"#$%&�A Phase II Prospec-

tive Study of Concurrent Chemoradiation

for the Untreated, Localized Nasal NK/

T-cell Lymphoma: A Proposal to TCOG

Trial�

14�TCOG �� 2003.9

TCOG�� !"#

�� !"#$%#&'()*�+,-.

�� !"#$%&'()*+,-./012

�� !"

�� !"#$��%&

�� ! 2003 � 8 � 23�� !"#$%

�� !"#$%&'()*+�� !"#$

�� !"#$�� !"#$%�RECIST �

�� !"#�� !"#$%�� SAE��

�� SAE Form�� !"�� T2202 ��

�� !"#$%&'()*+,-./012

��CRIMS�� !"#$%�� !"#$

�� !"#$%&'()**+,-.'/%

�� !"#$�%&'()*+,